AngioDynamics, Inc. ANGO Cash Flow

Angiodynamics, inc. (ANGO)

CashFlow / TTM

Feb'20	Nov'19	Aug'19	May'19	Feb'19	Nov'18	Aug'18	May'18	Feb'18	Nov'17	Aug'17	May'17	Feb'17	Nov'16	Aug'16	May'16	Feb'16	Nov'15	Aug'15	May'15	Feb'15	Nov'14	Aug'14	May'14	Feb'14	Nov'13	Aug'13	May'13	Feb'13	Nov'12	Aug'12	May'12	Feb'12	Nov'11	Aug'11	May'11	Feb'11	Nov'10	Aug'10
Cash flows from operating activities:
Net income (loss)
49,153	55,658	60,534	61,340	4,569	17,792	15,901	16,335	1,320	-9,812	3,673	5,008	-25,154	-27,447	-41,515	-43,590	-1,449	-6,305	-4,633	-3,388	-3,988	4,789	3,190	2,347	2,414	-3,093	-863	-1,211	-6,861	-7,637	-7,277	-5,183	1,073	6,652	7,602	8,117	0	0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization
24,272	24,699	25,488	25,880	24,926	23,777	22,969	23,163	23,751	24,202	24,451	24,811	25,281	26,091	27,155	28,115	28,374	30,172	30,274	29,861	29,992	28,458	29,119	28,329	29,769	28,936	27,268	27,227	23,786	20,564	17,413	14,676	12,928	12,868	12,682	12,579	0	0	0
Change in allowance for excess and obsolete inventory
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Stock based compensation
8,128	8,734	9,083	9,249	9,210	8,890	8,265	7,912	6,926	6,561	6,296	6,183	3,818	3,765	3,298	3,240	6,109	5,957	6,229	5,998	5,869	5,980	5,745	5,502	5,259	4,657	4,639	4,609	4,426	4,550	4,375	4,052	4,205	4,232	4,189	4,609	0	0	0
Amortization of acquired inventory basis step-up
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,845	0	0	0	-	-	-	-	-	-	-	-
Tax effect of exercise of stock options and issuance of performance shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	309	1,075	968	492	741	0	0	0
Change in fair value of contingent consideration
0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Gain on contingent consideration for IPR&D Write-off
0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0
Change in accounts receivable allowances
83	72	-427	-202	115	-176	-327	179	257	577	162	-313	417	1,429	2,071	2,377	2,144	1,441	1,430	1,448	843	498	397	465	589	644	568	338	102	-81	29	118	36	213	-14	-73	0	0	0
Fixed and intangible asset impairments and disposals
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fixed and intangible asset impairments and disposals
0	0	0	-	0	0	0	-	-	-	-	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Write-off of other assets
593	593	593	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-70	15	38	5	-25	65	13	605	686	567	1,171	586	445	225	-121	-90	-251	-9	-168	-181	-110	-65	-238	-130	12	-704	-4	-157	-990	-614	-1,339	-1,148	-361	135	206	-55	0	0	0
Changes in operating assets and liabilities:
Accounts receivable
-8,510	-9,355	-8,859	3,177	1,706	323	-1,379	-5,044	-4,478	-7,735	-8,760	-8,479	-7,537	-1,266	-28	-3,131	-1,052	-3,934	-2,205	-2,095	1,583	11,594	10,764	14,786	12,575	600	382	-1,020	-1,160	-3,617	-78	2,395	-1,702	5,902	2,714	-2,770	0	0	0
Inventories
12,762	10,482	5,820	1,428	-4,951	-4,187	-5,760	-5,740	-1,359	-2,843	-2,955	-687	-7,934	-13,891	-15,849	-11,976	-3,285	-4,960	3,383	5,648	10,099	15,844	11,828	6,114	-4,068	-3,692	-5,654	1,909	10,713	9,928	10,767	1,522	-1,086	-3,387	-3,662	-1,418	0	0	0
Prepaid expenses and other
9,741	4,232	1,417	1,871	2,191	1,711	3,051	1,231	2,853	3,755	2,031	3,520	-279	-2,385	-2,448	-712	-367	-401	939	1,170	-1,847	622	1,253	-1,208	2,379	1,204	-1,203	-977	320	3,703	6,448	6,000	5,603	1,143	-1,518	-2,050	0	0	0
Accounts payable, accrued and other liabilities
-2,455	6,460	1,008	5,212	-7,632	-12,716	-13,327	-7,093	10,822	15,895	14,494	19,214	-320	-2,250	-5,305	-2,956	-3,867	-1,962	-6,147	-6,254	-2,461	-2,760	5,278	6,788	3,244	560	-1,622	-9,711	-7,009	-1,171	1,387	6,582	6,658	4,404	3,627	-2,432	0	0	0
Net cash provided by operating activities
6,578	32,757	39,779	37,440	36,199	32,172	29,378	41,287	36,509	46,559	51,341	55,745	55,296	53,325	47,957	45,216	36,921	36,758	25,032	25,685	24,943	12,128	22,733	24,681	26,311	36,895	39,566	26,652	14,615	11,404	2,944	11,602	24,399	27,957	35,176	33,870	0	0	0
Cash flows from investing activities:
Additions to property, plant and equipment
6,571	5,716	3,827	3,118	3,047	2,585	2,572	2,391	2,390	2,377	3,021	3,001	2,689	3,004	2,064	2,326	2,240	5,028	7,022	11,383	13,207	11,504	13,373	11,172	13,415	14,524	14,055	12,120	8,321	6,221	2,919	2,492	2,864	2,526	2,836	2,957	0	0	0
Acquisition of intangibles
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for acquisitions
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Acquisition of businesses, net of cash acquired
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,169	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from disposal of intangible and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Purchases of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,134	10,425	51,096	86,273	123,614	136,809	117,854	202,714	168,476	0	0	0
Proceeds from sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	353	353	303	9,927	16,989	116,840	141,827	159,918	194,113	112,453	107,476	151,039	124,081	0	0	0
Net cash used in investing activities
106,561	118,766	118,695	82,554	-86,617	-88,770	-40,837	-3,656	-3,655	-2,377	-2,571	-2,551	-5,489	-7,822	-7,307	-7,569	-4,582	-6,106	-8,221	-12,736	-15,466	-13,014	-14,937	-16,448	-17,436	-27,006	-31,300	-22,238	-168,620	-173,938	-173,657	-176,234	-26,722	-13,472	-54,779	-48,620	0	0	0
Cash flows from financing activities:
Repayment of long-term debt
133,750	145,000	146,250	15,000	15,000	5,000	5,000	5,000	5,000	21,471	139,131	140,381	144,131	133,910	17,500	16,250	22,500	21,250	20,000	20,000	10,000	5,000	147,500	146,250	146,875	147,500	5,625	7,500	11,970	10,165	8,360	6,550	270	265	260	260	0	0	0
Deferred financing costs on long-term debt
775	741	741	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment of acquisition related contingent consideration
-8,992	-8,992	-8,992	-8,100	-16,900	-16,900	-9,500	-9,500	-10,200	-10,200	-9,850	-9,850	-9,850	-9,850	-9,850	-9,850	-12,594	-12,594	-11,222	-11,222	-19,318	-14,021	-14,793	-15,943	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds (outlays) from exercise of stock options and employee stock purchase plan
-698	-123	26	2,031	2,412	2,065	2,842	2,949	2,989	6,032	8,707	10,698	10,773	7,611	3,961	2,437	2,077	4,884	6,077	5,757	5,849	3,414	2,725	2,444	2,326	1,871	1,313	1,214	1,140	1,582	2,131	3,356	3,380	3,612	3,034	2,080	0	0	0
Net cash provided by (used) in financing activities
-127,431	-153,072	-99,173	33,931	40,312	49,965	-11,658	-11,551	-17,257	-30,843	-38,724	-37,983	-35,912	-28,695	-23,389	-23,663	-30,273	-26,216	-10,145	-10,465	3,281	549	-16,135	-14,016	-18,413	-14,196	-5,262	-6,286	136,806	139,053	139,303	142,338	1,108	1,345	2,876	1,922	0	0	0
Effect of exchange rate changes on cash and cash equivalents
-252	-24	-414	-380	-482	-403	-321	472	1,124	853	743	0	-221	-140	-118	-42	127	-317	-206	-198	-436	41	82	86	64	-73	-66	-65	8	79	44	49	5	-7	18	49	0	0	0
Decrease in cash and cash equivalents
-14,544	-1,573	58,887	153,545	-10,588	-7,036	-23,438	26,552	16,721	14,192	10,789	15,211	13,674	16,668	17,143	13,942	2,193	4,119	6,460	2,286	12,322	-296	-8,257	-5,697	-9,474	-4,380	2,938	-1,937	-17,191	-23,402	-31,366	-22,245	-1,210	15,823	-16,709	-12,779	0	0	0
Supplemental disclosure of non-cash investing and financing activities:
Contractual obligations for acquisition of intangibles and business
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-2,721	2,249	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Accrual for capital expenditures incurred during the period
142	349	325	-114	-81	-61	56	56	22	102	12	26	137	-131	16	75	-34	314	251	140	3,981	4,300	2,307	4,970	871	-236	1,443	1,549	0	0	0	-	-	-	0	-	-	-	-